148 related articles for article (PubMed ID: 9539780)
1. Chimeric anti-angiogenin antibody cAb 26-2F inhibits the formation of human breast cancer xenografts in athymic mice.
Piccoli R; Olson KA; Vallee BL; Fett JW
Proc Natl Acad Sci U S A; 1998 Apr; 95(8):4579-83. PubMed ID: 9539780
[TBL] [Abstract][Full Text] [Related]
2. Humanization of an anti-vascular endothelial growth factor monoclonal antibody for the therapy of solid tumors and other disorders.
Presta LG; Chen H; O'Connor SJ; Chisholm V; Meng YG; Krummen L; Winkler M; Ferrara N
Cancer Res; 1997 Oct; 57(20):4593-9. PubMed ID: 9377574
[TBL] [Abstract][Full Text] [Related]
3. Angiogenin antagonists prevent tumor growth in vivo.
Olson KA; Fett JW; French TC; Key ME; Vallee BL
Proc Natl Acad Sci U S A; 1995 Jan; 92(2):442-6. PubMed ID: 7831307
[TBL] [Abstract][Full Text] [Related]
4. Chimeric anti-ganglioside GM2 antibody with antitumor activity.
Nakamura K; Koike M; Shitara K; Kuwana Y; Kiuragi K; Igarashi S; Hasegawa M; Hanai N
Cancer Res; 1994 Mar; 54(6):1511-6. PubMed ID: 8137257
[TBL] [Abstract][Full Text] [Related]
5. Construction and expression of chimeric antibodies by a simple replacement of heavy and light chain V genes into a single cassette vector.
Kanda H; Mori K; Koga H; Taniguchi K; Kobayashi H; Sakahara H; Konishi J; Endo K; Watanabe T
Hybridoma; 1994 Oct; 13(5):359-66. PubMed ID: 7860092
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody.
Olson KA; Byers HR; Key ME; Fett JW
Int J Cancer; 2002 Apr; 98(6):923-9. PubMed ID: 11948474
[TBL] [Abstract][Full Text] [Related]
7. Cloning and sequencing of the VH and V kappa genes of an anti-CD3 monoclonal antibody, and construction of a mouse/human chimeric antibody.
Arakawa F; Kuroki M; Kuwahara M; Senba T; Ozaki H; Matsuoka Y; Misumi Y; Kanda H; Watanabe T
J Biochem; 1996 Sep; 120(3):657-62. PubMed ID: 8902633
[TBL] [Abstract][Full Text] [Related]
8. A monoclonal antibody to human angiogenin. Inhibition of ribonucleolytic and angiogenic activities and localization of the antigenic epitope.
Fett JW; Olson KA; Rybak SM
Biochemistry; 1994 May; 33(18):5421-7. PubMed ID: 7514035
[TBL] [Abstract][Full Text] [Related]
9. Anti-BA46 monoclonal antibody Mc3: humanization using a novel positional consensus and in vivo and in vitro characterization.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Cancer Res; 1995 Apr; 55(8):1717-22. PubMed ID: 7712480
[TBL] [Abstract][Full Text] [Related]
10. Binding activities and antitumor properties of a new mouse/human chimeric antibody specific for GD2 ganglioside antigen.
Alvarez-Rueda N; Leprieur S; Clémenceau B; Supiot S; Sébille-Rivain V; Faivre-Chauvet A; Davodeau F; Paris F; Barbet J; Aubry J; Birklé S
Clin Cancer Res; 2007 Sep; 13(18 Pt 2):5613s-5620s. PubMed ID: 17875797
[TBL] [Abstract][Full Text] [Related]
11. The crystal structure of human angiogenin in complex with an antitumor neutralizing antibody.
Chavali GB; Papageorgiou AC; Olson KA; Fett JW; Hu Gf; Shapiro R; Acharya KR
Structure; 2003 Jul; 11(7):875-85. PubMed ID: 12842050
[TBL] [Abstract][Full Text] [Related]
12. Generation, characterization, and in vivo studies of humanized anticarcinoma antibody CC49.
Kashmiri SV; Shu L; Padlan EA; Milenic DE; Schlom J; Hand PH
Hybridoma; 1995 Oct; 14(5):461-73. PubMed ID: 8575795
[TBL] [Abstract][Full Text] [Related]
13. Development and functional characterization of a murine/human chimeric antibody with specificity for the human interleukin-2 receptor.
Vandevyver C; Steukers M; Lambrechts J; Heyligen H; Raus J
Mol Immunol; 1993 Jul; 30(10):865-76. PubMed ID: 8341281
[TBL] [Abstract][Full Text] [Related]
14. New chimeric anti-pancarcinoma monoclonal antibody with superior cytotoxicity-mediating potency.
Velders MP; Litvinov SV; Warnaar SO; Gorter A; Fleuren GJ; Zurawski VR; Coney LR
Cancer Res; 1994 Apr; 54(7):1753-9. PubMed ID: 8137290
[TBL] [Abstract][Full Text] [Related]
15. Cloning of cDNAs encoding the variable domains of antibody KC4G3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Aug; 12(4):485-9. PubMed ID: 8244420
[TBL] [Abstract][Full Text] [Related]
16. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice.
Olson KA; French TC; Vallee BL; Fett JW
Cancer Res; 1994 Sep; 54(17):4576-9. PubMed ID: 8062244
[TBL] [Abstract][Full Text] [Related]
17. Cloning of cDNAs encoding the variable domains of antibody BrE-3 and construction of a chimeric antibody.
Couto JR; Blank EW; Peterson JA; Ceriani RL
Hybridoma; 1993 Feb; 12(1):15-23. PubMed ID: 8454302
[TBL] [Abstract][Full Text] [Related]
18. Molecular modeling and preclinical evaluation of the humanized NR-LU-13 antibody.
Graves SS; Goshorn SC; Stone DM; Axworthy DB; Reno JM; Bottino B; Searle S; Henry A; Pedersen J; Rees AR; Libby RT
Clin Cancer Res; 1999 Apr; 5(4):899-908. PubMed ID: 10213227
[TBL] [Abstract][Full Text] [Related]
19. Construction and characterization of a chimeric fusion protein consisting of an anti-idiotype antibody mimicking a breast cancer-associated antigen and the cytokine GM-CSF.
Tripathi PK; Qin H; Bhattacharya-Chatterjee M; Ceriani RL; Foon KA; Chatterjee SK
Hybridoma; 1999 Apr; 18(2):193-202. PubMed ID: 10380019
[TBL] [Abstract][Full Text] [Related]
20. Organogenesis and angiogenin.
Vallee BL; Riordan JF
Cell Mol Life Sci; 1997 Oct; 53(10):803-15. PubMed ID: 9413551
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
